• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.

作者信息

Bertrand Dominique, Laurent Charlotte, Lemée Veronique, Lebourg Ludivine, Hanoy Mélanie, Le Roy Frank, Nezam Dorian, Pruteanu Diana, Grange Steven, de Nattes Tristan, Lemoine Mathilde, Candon Sophie, Guerrot Dominique

机构信息

Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.

Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.

出版信息

Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23.

DOI:10.1016/j.kint.2022.05.007
PMID:35618097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9125992/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c87/9125992/2f86cbf6a7f7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c87/9125992/31363e35a185/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c87/9125992/2f86cbf6a7f7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c87/9125992/31363e35a185/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c87/9125992/2f86cbf6a7f7/gr2_lrg.jpg

相似文献

1
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.抗SARS-CoV-2单克隆抗体预防和疫苗接种对肾移植受者中新冠病毒奥密克戎变异株的疗效
Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23.
2
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.通过 SARS-CoV-2 变异株时代的肾移植受者中 COVID-19 的结局：抗 SARS-CoV-2 单克隆抗体的作用。
Transpl Int. 2022 Oct 4;35:10721. doi: 10.3389/ti.2022.10721. eCollection 2022.
3
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
4
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.肾移植受者在接种第三剂新冠疫苗后，新冠病毒2型免疫球蛋白G抗体产生的动力学延迟
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
5
Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.肾移植受者及其密切的家庭同居者同时接种新冠疫苗。
Kidney Int. 2022 May;101(5):1077-1080. doi: 10.1016/j.kint.2022.02.015. Epub 2022 Mar 16.
6
and Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients.肾移植受者中抗SARS-CoV-2变体单克隆抗体的中和效力
Transpl Int. 2024 Jul 16;37:13272. doi: 10.3389/ti.2024.13272. eCollection 2024.
7
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?肾移植受者的新型冠状病毒 2 型疫苗接种：我们是否应考虑皮内接种？
J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.
8
Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients.两剂严重急性呼吸综合征冠状病毒2疫苗接种对肾移植受者的现实世界影响
Transplantation. 2022 May 1;106(5):e279-e280. doi: 10.1097/TP.0000000000004081. Epub 2022 Mar 4.
9
Immunogenicity of Anti-SARS-CoV-2 Vaccination After Kidney Transplantation in Kidney Transplant Recipients Vaccinated Before Transplantation.肾移植受者在移植前接种抗SARS-CoV-2疫苗后的免疫原性。
Transplantation. 2023 Aug 1;107(8):e213-e214. doi: 10.1097/TP.0000000000004654. Epub 2023 May 22.
10
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.墨西哥与 SARS-CoV-2 变异株和疫苗接种相关的肾移植受者 COVID-19 死亡率。
Transplant Proc. 2022 Jul-Aug;54(6):1434-1438. doi: 10.1016/j.transproceed.2022.05.010. Epub 2022 Jun 1.

引用本文的文献

1
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.系统疫苗学确定了实体器官移植受者中SARS-CoV-2疫苗反应的免疫相关因素。
NPJ Vaccines. 2025 Jul 1;10(1):140. doi: 10.1038/s41541-025-01182-1.
2
Unveiling protection: a meta-analysis of tixagevimab-cilgavimab prophylaxis in 28,950 transplant recipients and immunocompromised patients against COVID-19.揭示保护作用：对28950名移植受者和免疫功能低下患者使用替沙格韦单抗-西加韦单抗预防COVID-19的荟萃分析
Virol J. 2025 Jun 2;22(1):178. doi: 10.1186/s12985-025-02814-7.
3
Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study.
替沙格韦单抗-西加韦单抗预防透析患者新冠病毒突破性感染的前瞻性研究
Clin Kidney J. 2024 Oct 18;17(11):sfae309. doi: 10.1093/ckj/sfae309. eCollection 2024 Nov.
4
Editorial: Therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies.社论：免疫功能低下患者新冠病毒病的治疗管理及其与免疫反应的相互作用：从预防到治疗策略
Front Immunol. 2024 Jul 16;15:1441199. doi: 10.3389/fimmu.2024.1441199. eCollection 2024.
5
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.替沙格韦单抗/西加韦单抗在免疫功能低下个体中用于新冠病毒暴露前预防的真实世界应用：来自章鱼研究的数据
Vaccines (Basel). 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784.
6
Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial.膳食菊粉改善肾移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的反应：RIVASTIM-菊粉随机对照试验
Vaccines (Basel). 2024 Jun 3;12(6):608. doi: 10.3390/vaccines12060608.
7
Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis.替沙格韦单抗/西加韦单抗预防实体器官移植受者感染新型冠状病毒肺炎的系统评价与Meta分析
Clin Transplant Res. 2024 Jun 30;38(2):136-144. doi: 10.4285/ctr.24.0015. Epub 2024 Jun 21.
8
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.mRNA 疫苗接种后肾移植受者对 SARS-CoV-2 奥密克戎亚变种的中和抗体反应和细胞反应。
Sci Rep. 2024 May 28;14(1):12176. doi: 10.1038/s41598-024-63147-z.
9
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study.替沙格韦单抗/西加韦单抗用于肾移植受者暴露前预防的安全性和有效性：一项多中心回顾性队列研究。
J Nephrol. 2024 Jul;37(6):1539-1550. doi: 10.1007/s40620-024-01889-9. Epub 2024 May 23.
10
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose.接受单克隆抗体预防的肾移植受者对SARS-CoV-2的T细胞反应评估及二价mRNA疫苗加强剂量的效用
Microorganisms. 2024 Apr 2;12(4):722. doi: 10.3390/microorganisms12040722.